PMCPA Case
| Case number | AUTH/3028/3/18 |
| Complainant | Ex-employee (contactable) |
| Company | AbbVie |
| Product | Synagis (palivizumab) |
| Main issues | Disclosure of company involvement in poster; uncertified case-study (Pathways) document used at promotional meeting(s) |
| Applicable Code year | 2016 |
| Complaint received | 23 March 2018 |
| Case completed | 17 October 2018 |
| Breach clauses | 9.1, 9.10, 14.1 |
| No breach clauses | 2, 15.2 |
| Sanctions | Undertaking received |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.